Commercial traction: The Company supplied 70 ARC-EX® Systems for use in clinics and homes. ARC-EX was available in more than 100 clinics across the US and Europe by the end of the first quarter.
Clinical milestones: The Company announced additional implants across its ARC-IM® and ARC-BCI® platforms, including the first participant enrollment and first successful implant in the Empower BP global pivotal study.
Financial highlights: The Company reported EUR 2.0 million in revenue in Q1 and a cash balance of EUR 53.4 million, before raising over EUR 40 million in equity capital in April, extending its cash runway into Q1 2028.
"Launch of ARC-EX continues to be a resounding success, with strong initial home-use sales in the US and rapid traction within the Veteran Affairs community. We advanced our deep pipeline in Q1 with first enrollment and first implant in Empower BP, the global pivotal study to evaluate the investigational ARC-IM System to address blood pressure instability after spinal cord injury. 12 Empower BP sites have now been activated," said Dave Marver, CEO of ONWARD Medical. "We were also proud to raise an additional EUR 40 million in equity capital, strengthening our balance sheet and fueling our ability to advance our commercial and clinical pursuits with speed and scale."
Commercial traction
The Company supplied 70 ARC-EX Systems in the first quarter, demonstrating continued robust demand for its groundbreaking external spinal cord stimulation technology. This includes the first systems delivered to individuals for home use, including those in the US Veterans Affairs community. The expansion into home use meets the demand for broader and more convenient access to the first US FDA-cleared technology indicated to improve hand strength and sensation after SCI.
ARC-EX Therapy is now available in over 100 clinics across the US and Europe.
Clinical milestones
ARC-IM
The first participant enrollment and first successful implant in the Empower BP pivotal study occurred in the first quarter of 2026 at Craig Hospital in Denver, Colorado. Empower BP is the first global pivotal study designed to assess the safety ...
